TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
Eilean Therapeutics
University of Manitoba
Eilean Therapeutics
National Cancer Institute (NCI)
University of Miami
University of Turin, Italy
University of Arizona
Novartis
Shenzhen TargetRx Co., Ltd.
Assistance Publique - Hôpitaux de Paris
Novartis
Thomas Jefferson University
Jonsson Comprehensive Cancer Center
University of Manchester
Peking University People's Hospital
Peking Union Medical College Hospital
Cancer Research UK
Ono Pharmaceutical Co. Ltd
Assiut University
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Hannover Medical School
Washington University School of Medicine
Brigham and Women's Hospital